Characterization of TIM3 and its ligands in colorectal cancer


Sandra Algaze, Yasmine Baca, Pavel Brodskiy, Joanne Xiu, Francesca Battaglin, Yan Yang, Joshua Millstein, Priya Jayachandran, Hiroyuki Arai, Shivani Soni, Wu Zhang, Richard M. Goldberg, Benjamin Adam Weinberg, Emil Lou, Anthony Frank Shields, John Marshall, Wolfgang Michael Korn, Heinz-Josef Lenz

Key Finding:

Strong associations were identified for GAL9/TIM3 expression and immuno-oncology markers, distinct molecular features, CMS, tumor microenvironment cell infiltration, and patient outcomes in colorectal cancer. 

Download Publication